2. Academic Validation
  3. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

  • Bioorg Med Chem Lett. 2001 Jul 9;11(13):1793-6. doi: 10.1016/s0960-894x(01)00304-3.
M L Barreca 1,  A Chimirri,  L De Luca,  A M Monforte,  P Monforte,  A Rao,  M Zappalà,  J Balzarini,  E De Clercq,  C Pannecouque,  M Witvrouw
Affiliations

Affiliation

  • 1 Dipartimento Farmaco-Chimico, Università di Messina, Viale Annunziata, 98168, Messina, Italy.
PMID: 11425562 DOI: 10.1016/s0960-894x(01)00304-3
Abstract

Design, synthesis and anti-HIV activity of a series of 2,3-diaryl-1,3-thiazolidin-4-ones are reported. Some derivatives proved to be highly effective in inhibiting HIV-1 replication at nanomolar concentrations thereby acting as non-nucleoside HIV-1 RT inhibitors (NNRTIs). SAR studies evidenced that the nature of the substituents at the 2 and 3 positions of the thiazolidinone nucleus largely influenced the in vitro anti-HIV activity of this new class of potent Antiviral agents.

Figures